BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/12/2026 10:07:40 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-09-03 06:10 |
|
Peer-Review Started |
|
2025-09-03 06:10 |
|
First Decision by Editorial Office Director |
|
2025-09-16 07:50 |
|
Return for Revision |
|
2025-09-16 07:50 |
|
Revised |
|
2025-09-20 03:41 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-25 02:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-25 05:43 |
|
Articles in Press |
|
2025-11-25 05:43 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-04 02:07 |
|
Publish the Manuscript Online |
|
2026-01-12 10:07 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Advances in radiofrequency ablation for pancreatic cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Si-Yu Peng, Zong-Yang Li and Hong-Qiao Cai |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hong-Qiao Cai, Associate Professor, MD, PhD, Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, No. 1 Xinmin Street, Changchun 130021, Jilin Province, China. hongqiaocai@jlu.edu.cn |
| Key Words |
Pancreatic cancer; Endoscopic ultrasound-guided radiofrequency ablation; Radiofrequency ablation; Combination therapy; Chemotherapy; Immunotherapy |
| Core Tip |
This article highlights the evolving role of endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) in the treatment of pancreatic cancer. Advances in energy delivery, probe design, and real-time imaging have enhanced the safety and precision of EUS-RFA. When combined with chemotherapy, EUS-RFA shows promise in improving survival outcomes and symptom control. Moreover, its immunomodulatory effects offer a novel rationale for combination with immunotherapy. Despite encouraging results, further randomized trials and standardization of protocols are needed to establish EUS-RFA as a mainstream component of pancreatic cancer treatment. |
| Publish Date |
2026-01-12 10:07 |
| Citation |
Peng SY, Li ZY, Cai HQ. Advances in radiofrequency ablation for pancreatic cancer. World J Gastrointest Oncol 2026; 18(1): 113764 |
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i1/113764.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v18.i1.113764 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
